In a Chinese Orthopedic acquisition, Mindray Medical Acquires Dragonbio for $35.5M

By

Mindray Medical to Acquire Controlling Stake in Dragonbio's Orthopedics Business for US$35.5 Million (press release)
Mindray video introduction
Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today a definitive agreement to acquire a controlling stake of Wuhan Dragonbio Surgical Implant Co., Ltd. ("Dragonbio"), a domestic medical orthopedic products provider that specializes in trauma, spine, joint and other surgical products. Under the agreement, Mindray will pay a total purchase price of approximately US...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.